Definitive Contract 75D30119C05279
Award Date 7/15/19
Potential Completion Date 7/14/20
Potential Value $151K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $275,000.00 definitive, firm fixed price contract to the University of Texas Health Science Center at Houston (UTHealth) for INVASIVE MOLD INFECTION DATA ACQUISITION services. This contract has no set-aside designation and was completed on September 30, 2020. UTHealth is a state-controlled institution of higher learning that provides healthcare services, medical education, and biomedical research. As...
- This is a prime contract awarded by the U.S. government to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract is for $6,155,674.00 and is a Definitive Contract with Cost No Fee pricing. The place of performance is Texas, USA. The contract is for biomedical (applied/exploratory) services and does not have a set-aside designation. MD Anderson Cancer Center, a comprehensive cancer treatment and research center, has received this prime...
- This is a federal contract award by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The University of Texas M.D. Anderson Cancer Center (MD Anderson) to provide additional funding for a previously awarded contract, 263-MJ-611300. The contract is a firm-fixed-price purchase order with a ceiling value of $100,000.00 and an ultimate completion date of September 30, 2008. The contract does not have a set-aside designation. MD Anderson...
- This is a federal contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of Texas MD Anderson Cancer Center (MD Anderson). The contract, valued at $20,094,324.00, is for the provision of cancer information services. The contract is a definitive contract with a cost-no-fee pricing type and has an ultimate completion date of January 14, 2010. MD Anderson, a comprehensive cancer treatment and research center, has received...
- This is an indefinite delivery contract (IDC) awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of Texas MD Anderson Cancer Center (MD Anderson) for $1,967,472.00 to provide support services for medical radiation dosimetry for epidemiology studies. The contract does not have a set-aside designation. MD Anderson, a comprehensive cancer treatment and research center that is part of the University of Texas System, has extensive...
- This is a federal contract award made by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System. The award, valued at $2,387,945.37, is for biomedical research and development activities, with an ultimate completion date of August 21, 2013. The contract is a definitive contract with a cost-no-fee pricing type, and does not have...
- This is a three-year, $13,481,325.00 definitive contract awarded by the National Cancer Institute (NCI) to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract supports a Phase II chemoprevention clinical trial in patients with adenomatous polyposis coli, a genetic condition that increases cancer risk. The contract does not have a small business set-aside designation. MD Anderson Cancer Center, a comprehensive cancer research and...
- This is a delivery order issued under the National Cancer Institute's Cancer Prevention Agent Development Program 2012-2017 indefinite delivery/indefinite quantity (IDIQ) contract. The contract was awarded to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to provide core infrastructure support for the program. The award has a ceiling value of $725,737.89 and an ultimate completion date of September 23, 2015. The contract is a cost-no-fee type...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract is part of the PREVENT Cancer Program, a preclinical research initiative focused on developing prevention strategies for breast cancer. The $714,123.60 contract supports "TARGETING THE MTOR PATHWAY FOR THE PREVENTION OF...
- This is a Delivery Order issued against the National Institutes of Health's PREVENT Cancer Program (PREVENT) Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The award, valued at $4,445.48, was made to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, for a "CONTRACT ORIENTATION AND KICKOFF MEETING" related to the PRECLINICAL PREVENT CANCER PROGRAM initiative. The award has an ultimate completion date of December 31, 2015 and does...